Human papillomavirus (HPV) vaccine for MSM: PGD template

Patient group direction (PGD) template to support the provision of HPV vaccine to men who have sex with men (MSM).


Human papillomavirus (HPV) vaccine, for MSM: PGD template

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.


This patient group direction (PGD) template supports the administration of HPV vaccine to MSM aged 45 years and under who attend Specialist Sexual Health Services (SSHS) and/or HIV clinics.

The HPV (MSM) PGD V02.00 is valid from 1 April 2020 to 31 March 2022.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy/procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.

Published 11 April 2018
Last updated 3 March 2020 + show all updates
  1. Added V2.00 following routine review.

  2. First published.